W
William C. Hahn
Researcher at Harvard University
Publications - 515
Citations - 85047
William C. Hahn is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 130, co-authored 448 publications receiving 72191 citations. Previous affiliations of William C. Hahn include Brigham and Women's Hospital & University of Washington.
Papers
More filters
Posted ContentDOI
Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers,Jordan Bryan,James M. McFarland,Barbara A. Weir,Ann E. Sizemore,Han Xu,Neekesh V. Dharia,Phillip G. Montgomery,Glenn S. Cowley,Sasha Pantel,Amy Goodale,Yenarae Lee,Levi D. Ali,Guozhi Jiang,Rakela Lubonja,William F. Harrington,Matthew Strickland,Ting Wu,Derek C. Hawes,Victor A. Zhivich,Meghan R. Wyatt,Zohra Kalani,Jaime J. Chang,Michael Okamoto,Todd R. Golub,Jesse S. Boehm,Francisca Vazquez,David E. Root,William C. Hahn,Aviad Tsherniak +29 more
TL;DR: CERES, a computational method to estimate gene dependency levels from CRISPR-Cas9 essentiality screens while accounting for the copy-number-specific effect, as well as variable sgRNA activity, is developed and applied to sets of screens performed with different sgRNAs and found that it reduces false positive results and provides meaningful estimates of sg RNA activity.
Journal ArticleDOI
Minimizing the risk of reporting false positives in large-scale RNAi screens
C Echeverri,Philip A. Beachy,Buzz Baum,Michael Boutros,Frank Buchholz,Sumit K. Chanda,Julian Downward,Jan Ellenberg,Andrew G. Fraser,Nir Hacohen,Nir Hacohen,William C. Hahn,William C. Hahn,Aimee L. Jackson,Amy A. Kiger,Peter S. Linsley,Lawrence G. Lum,Yong Ma,Bernard Mathey-Prevot,David E. Root,David M. Sabatini,Jussi Taipale,Norbert Perrimon,Norbert Perrimon,René Bernards +24 more
TL;DR: This Commentary is an invitation to an open discussion started among various users of RNAi to set forth accepted standards that would insure the quality and accuracy of information in the large datasets coming out of genome-scale screens.
Journal ArticleDOI
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G. Lohr,Jens G. Lohr,Viktor A. Adalsteinsson,Viktor A. Adalsteinsson,Kristian Cibulskis,Atish D. Choudhury,Atish D. Choudhury,Mara Rosenberg,Peter Cruz-Gordillo,Joshua M. Francis,Joshua M. Francis,Cheng-Zhong Zhang,Cheng-Zhong Zhang,Alex K. Shalek,Rahul Satija,John J. Trombetta,Diana Lu,Naren Tallapragada,Narmin Tahirova,Sora Kim,Brendan Blumenstiel,Carrie Sougnez,Alarice C. Lowe,Bang Wong,Daniel Auclair,Eliezer M. Van Allen,Eliezer M. Van Allen,Mari Nakabayashi,Rosina T. Lis,Gwo-Shu Mary Lee,Tiantian Li,Matthew S. Chabot,Amy Ly,Mary-Ellen Taplin,Thomas E. Clancy,Thomas E. Clancy,Massimo Loda,Aviv Regev,Aviv Regev,Aviv Regev,Matthew Meyerson,Matthew Meyerson,William C. Hahn,Philip W. Kantoff,Todd R. Golub,Gad Getz,Gad Getz,Jesse S. Boehm,J. Christopher Love,J. Christopher Love,J. Christopher Love +50 more
TL;DR: In this paper, whole-exome sequencing of circulating tumor cells enables accurate and powered calling of somatic point mutations, and the authors propose a method to identify the source of the point mutations.
Journal ArticleDOI
Complications during root canal irrigation--literature review and case reports.
Michael Hülsmann,William C. Hahn +1 more
TL;DR: Three cases of inadvertent injection of sodium hypochlorite and hydrogen peroxide beyond the root apex are presented and clinical symptoms are discussed, as well as preventive and therapeutic considerations.
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna Murthi Vasudevan,David A. Barbie,David A. Barbie,Michael A. Davies,Rosalia Rabinovsky,Chontelle J. McNear,Jessica J. Kim,Bryan T. Hennessy,Hsiuyi Tseng,Panisa Pochanard,So Young Kim,So Young Kim,Ian F. Dunn,Anna C. Schinzel,Anna C. Schinzel,Peter Sandy,Sebastian Hoersch,Qing Sheng,Piyush Gupta,Jesse S. Boehm,Jan H. Reiling,Serena J. Silver,Yiling Lu,Katherine Stemke-Hale,Bhaskar Dutta,Corwin Joy,Aysegul A. Sahin,Ana M. Gonzalez-Angulo,Ana Lluch,Lucia E. Rameh,Tyler Jacks,David E. Root,Eric S. Lander,Gordon B. Mills,William C. Hahn,William R. Sellers,William R. Sellers,Levi A. Garraway +37 more
TL;DR: It is shown through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth.